Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sarepta halts its golodirsen Duchenne MD study in UK after patient experiences adverse event
Sarepta halts its golodirsen Duchenne MD study in UK after patient experiences adverse event
Sarepta halts its golodirsen Duchenne MD study in UK after patient experiences adverse event
Submitted by
admin
on February 9, 2018 - 9:35am
Source:
Endpoints
News Tags:
Sarepta Therapeutics
golodirsen
Duchenne Muscular Dystrophy
UK
Headline:
Sarepta halts its golodirsen Duchenne MD study in UK after patient experiences adverse event
Do Not Allow Advertisers to Use My Personal information
